{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:9047"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:9047","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Developing normothermic machine liver perfusion for improvement of marginal donor graft quality","abstract":"The studies incorporated in this thesis examined ways to develop ex situ normothermic machine perfusion (NMP) of the liver as a tool to enhance the reconditioning of high-risk extended criteria donor (ECD) organs. Two possible alternatives were investigated: (1) The use of hypothermic oxygenated machine perfusion as a therapeutic intervention preceding NMP; and (2) the delivery of a pharmacological combination of drugs targeting hepatic lipid metabolism during NMP. Using human donor livers discarded for transplantation, the feasibility of a combined protocol of hypothermic oxygenated perfusion (HOPE) and NMP was shown. HOPE optimised hepatic mitochondrial bioenergetic and oxidative status as well as mitigated ischaemia-reperfusion injury, while NMP maintained the organs’ metabolism thus allowing the assessment of its metabolic functions. This combined protocol was facilitated with the use of a single acellular haemoglobin-based oxygen carrier (HBOC)-based perfusate throughout the entire perfusion, using a cold-to-warm machine perfusion protocol. These combined protocols enabled superior recovery of metabolic functions of ECD livers compared to NMP alone. The delivery of a combination of drugs targeting the hepatic lipid metabolism during NMP was also investigated. This approach reduced the intracellular lipid content of discarded human donor livers via enhancement of fatty-acids β-oxidation and solubilisation of lipids in the perfusate. The boosted lipid metabolism improved the metabolic status of the organs optimising their functional recovery and halted oxidative stress-related hepatobiliary injury. These findings are promising and guarantee future clinical investigation, opening a window of opportunity to improve the reconditioning of ECD livers.","abstract_html":"The studies incorporated in this thesis examined ways to develop ex situ normothermic machine perfusion (NMP) of the liver as a tool to enhance the reconditioning of high-risk extended criteria donor (ECD) organs. Two possible alternatives were investigated: (1) The use of hypothermic oxygenated machine perfusion as a therapeutic intervention preceding NMP; and (2) the delivery of a pharmacological combination of drugs targeting hepatic lipid metabolism during NMP. Using human donor livers discarded for transplantation, the feasibility of a combined protocol of hypothermic oxygenated perfusion (HOPE) and NMP was shown. HOPE optimised hepatic mitochondrial bioenergetic and oxidative status as well as mitigated ischaemia-reperfusion injury, while NMP maintained the organs’ metabolism thus allowing the assessment of its metabolic functions. This combined protocol was facilitated with the use of a single acellular haemoglobin-based oxygen carrier (HBOC)-based perfusate throughout the entire perfusion, using a cold-to-warm machine perfusion protocol. These combined protocols enabled superior recovery of metabolic functions of ECD livers compared to NMP alone. The delivery of a combination of drugs targeting the hepatic lipid metabolism during NMP was also investigated. This approach reduced the intracellular lipid content of discarded human donor livers via enhancement of fatty-acids β-oxidation and solubilisation of lipids in the perfusate. The boosted lipid metabolism improved the metabolic status of the organs optimising their functional recovery and halted oxidative stress-related hepatobiliary injury. These findings are promising and guarantee future clinical investigation, opening a window of opportunity to improve the reconditioning of ECD livers.","abstract_has_math":false,"creators":["Boteon, Yuri Longatto"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019-07","date_published":"2019-07","updated_at":"2026-11-19T09:30:27Z","subjects":["QP Physiology","R Medicine (General)","RD Surgery","RM Therapeutics. Pharmacology","RZ Other systems of medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"person:identifier.orcid","label":"ORCID","values":["0000000217099284"],"render_values":[{"text":"0000-0002-1709-9284","href":"https://orcid.org/0000-0002-1709-9284","code":true}]}]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/9047/7/Boteon2019PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A9047","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["other"]},{"key":"dc:creator","label":"Author","values":["Boteon, Yuri Longatto"]},{"key":"person:identifier.orcid","label":"ORCID","values":["0000000217099284"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2019-07-17"]},{"key":"dc:date.issued","label":"Date","values":["2019-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/9047/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QP Physiology","R Medicine (General)","RD Surgery","RM Therapeutics. Pharmacology","RZ Other systems of medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/9047/7/Boteon2019PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The studies incorporated in this thesis examined ways to develop ex situ normothermic machine perfusion (NMP) of the liver as a tool to enhance the reconditioning of high-risk extended criteria donor (ECD) organs. Two possible alternatives were investigated: (1) The use of hypothermic oxygenated machine perfusion as a therapeutic intervention preceding NMP; and (2) the delivery of a pharmacological combination of drugs targeting hepatic lipid metabolism during NMP. Using human donor livers discarded for transplantation, the feasibility of a combined protocol of hypothermic oxygenated perfusion (HOPE) and NMP was shown. HOPE optimised hepatic mitochondrial bioenergetic and oxidative status as well as mitigated ischaemia-reperfusion injury, while NMP maintained the organs’ metabolism thus allowing the assessment of its metabolic functions. This combined protocol was facilitated with the use of a single acellular haemoglobin-based oxygen carrier (HBOC)-based perfusate throughout the entire perfusion, using a cold-to-warm machine perfusion protocol. These combined protocols enabled superior recovery of metabolic functions of ECD livers compared to NMP alone. The delivery of a combination of drugs targeting the hepatic lipid metabolism during NMP was also investigated. This approach reduced the intracellular lipid content of discarded human donor livers via enhancement of fatty-acids β-oxidation and solubilisation of lipids in the perfusate. The boosted lipid metabolism improved the metabolic status of the organs optimising their functional recovery and halted oxidative stress-related hepatobiliary injury. These findings are promising and guarantee future clinical investigation, opening a window of opportunity to improve the reconditioning of ECD livers."]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Developing normothermic machine liver perfusion for improvement of marginal donor graft quality"]}]}],"canonical_facts":{"dc:contributor.sponsor":["other"],"dc:creator":["Boteon, Yuri Longatto"],"dc:date":["2019-07-17"],"dc:date.issued":["2019-07"],"dc:description.abstract":["The studies incorporated in this thesis examined ways to develop ex situ normothermic machine perfusion (NMP) of the liver as a tool to enhance the reconditioning of high-risk extended criteria donor (ECD) organs. Two possible alternatives were investigated: (1) The use of hypothermic oxygenated machine perfusion as a therapeutic intervention preceding NMP; and (2) the delivery of a pharmacological combination of drugs targeting hepatic lipid metabolism during NMP. Using human donor livers discarded for transplantation, the feasibility of a combined protocol of hypothermic oxygenated perfusion (HOPE) and NMP was shown. HOPE optimised hepatic mitochondrial bioenergetic and oxidative status as well as mitigated ischaemia-reperfusion injury, while NMP maintained the organs’ metabolism thus allowing the assessment of its metabolic functions. This combined protocol was facilitated with the use of a single acellular haemoglobin-based oxygen carrier (HBOC)-based perfusate throughout the entire perfusion, using a cold-to-warm machine perfusion protocol. These combined protocols enabled superior recovery of metabolic functions of ECD livers compared to NMP alone. The delivery of a combination of drugs targeting the hepatic lipid metabolism during NMP was also investigated. This approach reduced the intracellular lipid content of discarded human donor livers via enhancement of fatty-acids β-oxidation and solubilisation of lipids in the perfusate. The boosted lipid metabolism improved the metabolic status of the organs optimising their functional recovery and halted oxidative stress-related hepatobiliary injury. These findings are promising and guarantee future clinical investigation, opening a window of opportunity to improve the reconditioning of ECD livers."],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/9047/7/Boteon2019PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/9047/"],"dc:subject":["QP Physiology","R Medicine (General)","RD Surgery","RM Therapeutics. Pharmacology","RZ Other systems of medicine"],"dcterms:accessrights":["public"],"dc:title":["Developing normothermic machine liver perfusion for improvement of marginal donor graft quality"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"],"person:identifier.orcid":["0000000217099284"]},"updated_at":"2026-11-19T09:30:27Z"}